Boston
Most Read
Vaccine experts say Moderna didn’t produce data critical to assessing Covid-19 vaccine
First data for Moderna Covid-19 vaccine show it spurs an immune response
Researchers rush to test coronavirus vaccine in people without knowing how well it works in animals
Moderna executives have cashed out $89M in shares this year, as stock price has soared on vaccine hopes
Here come the tortoises: In the race for a Covid-19 vaccine, slow starters could still win out
In the Covid-19 death of a hospital food worker, a microcosm of the pandemic
A leading AI researcher calls for standards to ensure equity and fairness
All Coverage
advertisement
